International Journal of
Reproductive Biomedicine
Wed, Apr 24, 2024
[Archive]
Volume 12, Issue 2 (2-2014)
IJRM 2014, 12(2): 145-150 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nikbakht R, Taheri Moghadam M, Ghane’ee H. Nifedipine compared to magnesium sulfate for treating preterm labor: A randomized clinical trial. IJRM 2014; 12 (2) :145-150
URL: http://ijrm.ir/article-1-507-en.html
URL: http://ijrm.ir/article-1-507-en.html
1- Department of Obstetrics and Gynecology, Ahvaz Jondishapour University of Medical Sciences, Ahvaz, Iran
2- Department of Pathology, Ahvaz Jondishapour University of Medical Sciences, Ahvaz, Iran , Taherimoghadam-m@AJUMS.ac.ir
2- Department of Pathology, Ahvaz Jondishapour University of Medical Sciences, Ahvaz, Iran , Taherimoghadam-m@AJUMS.ac.ir
Abstract: (2325 Views)
Background: Preterm labor is the leading cause of infant morbidity and mortality so it may be necessary to administer tocolytics for treatment of it.
Objective: The aim of this study was to compare the efficacy and safety of magnesium sulfate and nifedipine in the management of preterm labor.
Materials and Methods: 100 women with documented preterm labor were randomly assigned to receive magnesium sulfate (n=50) and nifedipine (n=50) as tocolytic therapy. Before tocolysis, patient did not receive any sedation. After tocolysis, if patient continued to have contractions, they received other tocolytic agents. The main outcome variables examined were days gain in utero, success rate and side effects of tocolysis.
Results: Both drugs were equally effective in prevention of labor and delaying delivery >7 days, 56% vs. 64% in the nifedipine and magnesium sulfate groups, and the days gain in utero was no statistically different in two groups. 6% of nifedipine group and 2% of magnesium sulfate group required drug discontinuation due to severe symptoms. There were also no significant differences in maternal characteristics between two groups. The total success rate and side effects were similar in two groups.
Conclusion: Oral nifedipine could be a suitable alternative for magnesium sulfate with the same efficacy and side effects in the management of preterm labor.
Objective: The aim of this study was to compare the efficacy and safety of magnesium sulfate and nifedipine in the management of preterm labor.
Materials and Methods: 100 women with documented preterm labor were randomly assigned to receive magnesium sulfate (n=50) and nifedipine (n=50) as tocolytic therapy. Before tocolysis, patient did not receive any sedation. After tocolysis, if patient continued to have contractions, they received other tocolytic agents. The main outcome variables examined were days gain in utero, success rate and side effects of tocolysis.
Results: Both drugs were equally effective in prevention of labor and delaying delivery >7 days, 56% vs. 64% in the nifedipine and magnesium sulfate groups, and the days gain in utero was no statistically different in two groups. 6% of nifedipine group and 2% of magnesium sulfate group required drug discontinuation due to severe symptoms. There were also no significant differences in maternal characteristics between two groups. The total success rate and side effects were similar in two groups.
Conclusion: Oral nifedipine could be a suitable alternative for magnesium sulfate with the same efficacy and side effects in the management of preterm labor.
Type of Study: Original Article |
References
1. De Heus R, Mulder EJ, Visser HA. Management of preterm labor: atosiban or nifedipine? Int J Womens Health 2010; 2: 137-142. [DOI:10.2147/IJWH.S7219]
2. Swingle HM, Colaizy TT, Zimmerman MB, Morriss FH. Abortion and the risk of subsequent preterm birth: a systematic review with meta-analyses. J Reprod Med 2009; 54: 95-108.
3. Dolan SM, Gross SG, Merkatz IR, Faber V, Sullivan LM, et.al. The contribution of birth defects to preterm birth and low birth weight. Obstet Gynecol 2007; 110: 318-324. [DOI:10.1097/01.AOG.0000275264.78506.63]
4. Berkman ND, Thorp JM, Lohr KN, Carey TS, Hartmann KE, et al. Tocolytic treatment for the management of preterm labor: A review of the evidence. Am J Obstet Gynecol 2003; 188: 1648-1659. [DOI:10.1067/mob.2003.356]
5. Yasuyuki K, Sameshima H, Ikenoue T, Yasuhi I, Kawarabayashi T. Magnesium sulfate as a second-line tocolytic agent for preterm labor: A randomized controlled trial in Kyushu Island. J Pregnancy 2011; 2011: 1-6.
6. Mercer BM, Merlino AA. Magnesium sulfate for preterm labor and preterm birth. Obstet Gynecol 2009; 114: 650-668. [DOI:10.1097/AOG.0b013e3181b48336]
7. Grimes DA, Kavita Nanda K. Magnesium sulfate tocolysis time to quit. Obstet Gynecol 2006; 108: 986-989. [DOI:10.1097/01.AOG.0000236445.18265.93]
8. King J, Flenady V, Papatsonis DNM, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine. Aust N Z J Obstet Gynaecol 2003; 43: 192-198. [DOI:10.1046/j.0004-8666.2003.00074.x]
9. Papatsonis DNM, Kok JH, van Geijn HP, Bleker OP, Ader HJ, Dekker GA. Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet Gynecol 2000; 95: 477-481.
10. Conde-Agudelo A, Roberto Romero R, Juan Pedro Kusanovic JP. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol 2011; 204: 1-20. [DOI:10.1016/j.ajog.2010.11.038]
11. Lyell DJ, Pullen K, Campbell L, Ching S, Druzin ML, Chitkara U, et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: A randomized controlled trial. Obstet Gynecol 2007; 110: 61-67. [DOI:10.1097/01.AOG.0000269048.06634.35]
12. Goldenberg RL. The management of preterm labor. Obstet Gynecol 2002; 100: 1020-1037.
13. Taherian AA, Dehdar P. Comparison of efficacy and safety of nifedipine versus magnesium sulfate in treatment of preterm labor. J Reprod Med Sci 2007; 12: 136-142.
14. Kim JH, Ahn KH, Kim JY, Jeong YJ, Cho SN. A comparison for efficacy and safety of magnesium sulfate (Magrose), ritodrine hydrochloride (Yutopar) and nifedipine (Adalat) in the management of preterm labor. Korean J Obstet Gynecol 2001; 44: 1165-1170.
15. Larmon JE, Ross BS, May WL, Dickerson GA, Fischer RG, Morrison JC. Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. Am J Obstet Gynecol 1999; 181: 1432-1437. [DOI:10.1016/S0002-9378(99)70388-1]
16. Lindow SW, Davies N, Davey DA, Smith JA. The effect of sublingual nifedipine on uteroplacental bloodflow in hypertensive pregnancy. Br J Obstet Gynaecol 1988; 95: 1276-1281. [DOI:10.1111/j.1471-0528.1988.tb06818.x]
17. Pirhonen JP, Erkkola RU, Ekblad UU, Myman L. Single dose of nifedipine in normotensive pregnancy: Nifedipine concentration, hemodynamic responses and uterine and fetal flow velocity wave forms. Obstet Gynecol 1990; 76: 807-811. [DOI:10.1097/00006250-199011000-00016]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
